PrimeRFP SCOUT · Federal Contract Recompete Brief

HT001423F0145RADIUM RA 223 dichloride injection UCI — Cardinal Health 414, LLC

Cardinal Health 414, LLC holds $77.1M across 461 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent HT001420A0031. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Aug 31, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Defense Health Agency

Awarding office

Cardinal Health 414, LLC

Recipient

Aug 31, 2024

PoP end

$133K

Obligated

$133K

Potential

325412

NAICS

6505

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Cardinal Health 414, LLC — $90

Contract facts

NONE

Contract numberHT001423F0145

Also listed asHT0014-23-F-0145

Also listed asHT001420A0031-HT001423F0145

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentCardinal Health 414, LLC

CAGE3S229

UEICWN9UGL3NCL9

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVHT001420A0031

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startSep 1, 2023

PoP end (current)Aug 31, 2024

Obligated$133K

Current value$133K

Potential value$133K

RADIUM RA 223 DICHLORIDE INJECTION/UCI: WILL MANUFACTURER AS NEEDED PER PATIENT. DOSE IS ORDERED A WEEK PRIOR. is a federal NONE award for Defense Health Agency held by Cardinal Health 414, LLC. Estimated value $133K ($133K obligated). Current period of performance ends Aug 31, 2024. Last award drew 1 bidder. Place of performance: BETHESDA MD.

RADIUM RA 223 DICHLORIDE INJECTION/UCI: WILL MANUFACTURER AS NEEDED PER PATIENT. DOSE IS ORDERED A WEEK PRIOR.

Recompete timing

Public

● Past PoP end (720 days ago)

Current PoP ended Aug 31, 2024 (720 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Cardinal Health 414, LLC — $77.1M obligated across 461 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($77.1M) · all agencies

Department of Veterans Affairs (VA)$64.4M · 84%Department of Defense (DOD)$10.4M · 13%Department of Health and Human Services (HHS)$2.3M · 3%Department of Justice (DOJ)$47K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C24125P0544

RADIOPHARMACEUTICALS

$997K

Aug 29, 2026

36C25625N0998

FLUDEOXYGLUCOSE FDG F 18 - PET CT DOSE

$144K

Sep 14, 2026

36C24826N0035

RADIOPHARMACEUTICALS

$3.1M

Sep 30, 2026

W91YTZ21C0027

NEW FY22 RADIOPHARMACEUTICALS PR 0011603260

$2.8M

Sep 30, 2026

W91YTZ21P0135

MOD - FUND FY22 RADIOPHARMA

$2.0M

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT001423F0145?

HT001423F0145 (RADIUM RA 223 dichloride injection UCI) is a Defense Health Agency award with a potential value of $133K, currently held by Cardinal Health 414, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT0014-23-F-0145?

HT0014-23-F-0145 is the dashed form of PIID HT001423F0145 (RADIUM RA 223 dichloride injection UCI), held by Cardinal Health 414, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT001423F0145?

Defense Health Agency awarded HT001423F0145 to Cardinal Health 414, LLC (potential $133K).

Who is the incumbent on HT001423F0145?

Cardinal Health 414, LLC is the incumbent with $77.1M across 461 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2024.

When does Cardinal Health 414, LLC’s HT001423F0145 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 31, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Aug 31, 2023